Contact details of national competent authorities for requests to use a sticker to place the Unique Identifier on the outer/immediate packaging of centrally approved products

CTIS newsflash – 18 August 2023

10 years of the Healthcare Professionals' Working Party

Human medicines European public assessment report (EPAR): Nexpovio, selinexor, Multiple Myeloma, Date of authorisation: 26/03/2021, Revision: 8, Status: Authorised

Pharmacovigilance (veterinary medicines)

Signal management (veterinary medicines)

Human medicines European public assessment report (EPAR): Jalra, vildagliptin, Diabetes Mellitus, Type 2, Date of authorisation: 19/11/2008, Revision: 24, Status: Authorised

Human medicines European public assessment report (EPAR): Galvus, vildagliptin, Diabetes Mellitus, Type 2, Date of authorisation: 25/09/2007, Revision: 23, Status: Authorised

Human medicines European public assessment report (EPAR): Xiliarx, vildagliptin, Diabetes Mellitus, Type 2, Date of authorisation: 19/11/2008, Revision: 23, Status: Authorised

Development of a reflection paper on modern manufacturing techniques used for herbal preparations - Scientific guideline